{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008992","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.552361+00:00","generated_at":"2026-05-22T07:45:27.859772+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetVivo receives $200K on partial option exercise; extends Series B preferred offering option to June 26","bullets":["Received $200,000 on May 6, 2025 from partial exercise of Purchase Option under March 26 Subscription Agreement.","Purchase Option extended 30 days to June 26, 2025 for up to $4.2M remaining of $5M Series B Convertible Preferred offering.","Shares priced at $1.00 each; investor represented as accredited; securities unregistered and restricted.","Proceeds intended for commercialization of Spryng™, PrecisePRP, clinical trials, and working capital.","Option allows purchase of up to 4,400,000 additional shares at same terms; no minimum offering amount."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008992","json":"https://secwatch.observer/filing/0001641172-25-008992.json","markdown":"https://secwatch.observer/filing/0001641172-25-008992.md","text":"https://secwatch.observer/filing/0001641172-25-008992.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225008992/0001641172-25-008992-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225008992/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:45:27.859772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}